Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
M.D. Anderson Cancer Center Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for qualified medical advice, travels to or treatment using a genuine mD. We aren't mDs. Always confer with your doctor about M.D. Anderson Cancer Center clinical studies. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. M.D. Anderson Cancer Center Clinical research trials and M.D. Anderson Cancer Center healthcare trials occur in many of localities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectivity of new does drugs. The intent of the studies / undertakings is to resolve certain human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations like M.D. Anderson Cancer Center to locate treatments for all kinds of conditions. M.D. Anderson Cancer Center Clinical Trials and other clinical trials allow for volunteers to acquire medical treatment options before they are available to the general public. Some times the participants obtain treatment for free of charge, and every now and again they are compensated for their time. Sometimes there is a cost for a M.D. Anderson Cancer Center clinical trial. Subjects oftentimes obtain the best healthcare possible for their condition. Dangers are a reality, nevertheless, and might include more or frequent physician calls, medical dangers (perhaps life-endangering), and/or the treatment being ineffective. Trials are federally governed with rigid guidelines to protect clinical trials patients.

Home > "M" Clinical Trials Sponsors > M.D. Anderson Cancer Center Clinical Trials

M.D. Anderson Cancer Center Clinical Trials



506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

A Phase I Study of DT388GMCSF Fusion Protein in AML and CMML
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

A Phase II Study Of Yttrium-ibritumomab (Zevalan) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Allo Transplantation with Mylotarg, fludarabine and melphalan for AML, CML and MDS.
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Autologous Platelets
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Avastin Plus Rituximab for Patients with Relapsed and Chemotherapy - or Rituxan-Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

BMS-214662 in Treating Patients With Solid Tumors
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Celecoxib in Treating Patients With Bladder Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis.
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Chemotherapy, Interferon alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Cilengitide in Treating Patients With Metastatic Melanoma
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Clofarabine combinations in relapsed/refractory AML, MDS and myeloid blast phase CML
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Clofarabine plus cytarabine in patients with previously untreated acute myeloid leukemia and high-risk myelodysplastic syndrome
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Docetaxel in Treating Patients With Metastatic Breast Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Evaluation of Differing Taxanes/Taxane Combinations on the Outcomes of Patients with Operable Breast Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Fenretinide to Prevent Cancer Recurrence in Treating Patients With Bladder Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center

Hepatic Artery Infusion of CD34+ Cells
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center



M.D. Anderson Cancer Center Clinical Trials
Modify your Search

Other "M" Clinical Trials Sponsors:

M.d. Anderson Cancer Center
Massachusetts General Hospital
Massey Cancer Center
Maxim Pharmaceuticals
Mayo Clinic
Mayo Clinic Cancer Center
Mcneil Consumer & Specialty Pharmaceuticals
Medarex
Medical College Of Pennsylvania Hospital
Medical College Of Wisconsin
Medical Research Council
Medical Research Laboratories International
Medigene
Medimmune, Inc.
Medizinische Hochschule Hannover
Medsearch
Medstone International
Memorial Sloan-Kettering Cancer Center
Merck
Merck Research Laboratories
Merieux Institute
Metabasis Therapeutics
Metaphore Pharmaceuticals
Microgenesys
Micrologix Biotech
Mid-Atlantic Oncology Program
Midamerica Neuroscience Institute
Midwestern Regional Medical Center
Milkhaus Laboratory
Millennium Pharmaceuticals
Millennix
Milton S. Hershey Medical Center
Mitsubishi Pharma Corporation
Mount Sinai Medical Center
Mount Vernon Hospital
Mucos Pharma Gmbh And Co
Mylan Laboratories
Myogen
Myriad Pharmaceuticals


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103